共 50 条
Engineered Vancomycin, with Increased Interactions with Peptidoglycan Stem Peptide, Conquers Non-tuberculosis Mycobacteria
被引:0
|作者:
Vennard, Christopher
[1
,2
]
Oropo, Temitope
[1
]
Sintim, Herman O.
[1
,2
,3
]
机构:
[1] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA
[2] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA
[3] Purdue Univ, Inst Drug Discovery, W Lafayette, IN 47907 USA
关键词:
D O I:
10.1021/acs.jmedchem.3c01219
中图分类号:
R914 [药物化学];
学科分类号:
100701 ;
摘要:
Vancomycin-like drugs target peptidoglycan (PG) via binding to C-terminal d-Ala-d-Ala dipeptide. An engineered vancomycin has enhanced affinity for the PG stem peptide, due to probable interactions with a third residue, meso-diaminopimelic acid, in the PG. This engineered vancomycin displays enhanced killing of mycobacteria.
引用
收藏
页码:10238 / 10240
页数:3
相关论文